CYTRX (NQ:CYTR)
Delayed: 2.34 --0 (-0%)
Trade Now!
Previous Close $2.34    52 Week High $5.50 
Open $2.30    52 Week Low $1.59 
Day High $2.37    P/E N/A 
Day Low $2.25    EPS $-0.54 
Volume 19,936       


May 23, 2013 08:30 AM CytRx to Present at the Marcum MicroCap Conference
May 21, 2013 08:30 AM CytRx Announces Initial Results from Pharmacokinetics Clinical Trial with Aldoxorubicin in Solid Tumors
May 20, 2013 08:30 AM CytRx Issues Letter to Stockholders Providing Business Update
May 9, 2013 09:35 AM CytRx Corp (CYTR) Posts Q1 Loss of 23c/Share
May 9, 2013 08:31 AM Form 8-K CYTRX CORP For: May 09
May 9, 2013 08:30 AM CytRx Reports 2013 First Quarter Financial Results
May 9, 2013 08:29 AM Form 10-Q CYTRX CORP For: Mar 31
May 8, 2013 08:30 AM CytRx Provides Update on Clinical Programs
May 6, 2013 08:36 AM CytRx Corp (CYTR) Recommended to Continue Aldoxorubicin Phase 2b to Completion
May 6, 2013 08:30 AM CytRx Receives Recommendation from Data Safety Monitoring Committee to Complete International Phase 2b Trial with Aldoxorubicin as First-Line Treatment for Soft Tissue Sarcoma
View All Articles

Entities mentioned with CYTR

View All Entities